Examiner: DROUIN, STEVE HOANG

Tech Center 1600 • Art Units: 1627

This examiner grants 100% of resolved cases

Performance Statistics

100.0%

Allow Rate

+40.0% vs TC avg

Total Applications

+0.0%

Interview Lift

1103

Avg Prosecution Days

Based on 1 resolved cases, 2023–2026

3.7%

§101 Eligibility

33.3%

§102 Novelty

44.4%

§103 Obviousness

11.1%

§112 Clarity

App #	Title	Status	Assignee
18657004	PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES	Non-Final OA	Takeda Pharmaceutical Company Limited
18361492	METHODS OF TREATING A CORONAVIRUS INFECTION	Non-Final OA	City of Hope

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.